The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism

Blood

Volumn 128, Issue 17, 2016, Pages 2185-2188

  Schotten, Nienke ^a   Jong, Pieternel C M Pasker De ^a   Moretti, Diego ^b   Zimmermann, Michael B ^b   Geurts Moespot, Anneke J ^c   Swinkels, Dorine W ^c   Van Kraaij, Marian G J ^d  

^a SANQUIN RESEARCH   (Netherlands)

^b ETH ZURICH   (Switzerland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEME; HEMOGLOBIN; HEPCIDIN; IRON;

ADULT; ANEMIA; BLOOD DONOR; CLINICAL ARTICLE; ERYTHROCYTE; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; BLOOD; CONTROLLED STUDY; CONVALESCENCE; DONOR SELECTION; FEMALE; IRON DEFICIENCY ANEMIA; METABOLISM; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD DONORS; DONOR SELECTION; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 85012030361     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-04-709451     Document Type: Letter

References (25)

1. Cable RG, Glynn SA, Kiss JE, et al; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52(4):702-711.
2. Canadian Blood Services. Available at: www.blood.ca. Accessed 14 June 2016.
3. European Commission. Commission directive 2004/33/EC. Official Journal of the European Union. 2004;L 91:25-39.
4. Fowler WM, Barer AP. Rate of hemoglobin regeneration in blood donors. JAMA. 1942;118(6):421-427.
5. Wadsworth GR. Recovery from acute haemorrhage in normal men and women. J Physiol. 1955;129(3):583-593.
6. Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA. 1981; 245(20):2038-2043.
7. Mast AE. Low hemoglobin deferral in blood donors. Transfus Med Rev. 2014; 28(1):18-22.
8. Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. Zinc protoporphyrin as screening test in female blood donors. Clin Chem. 1998;44(4):800-804.
9. Hastka J, Lasserre JJ, Schwarzbeck A, Reiter A, Hehlmann R. Laboratory tests of iron status: correlation or common sense? Clin Chem. 1996;42(5):718-724.
10. Punnonen K, Rajamäki A. Evaluation of iron status of Finnish blood donors using serum transferrin receptor. Transfus Med. 1999;9(2):131-134.
11. Peffer K, Verbeek AL, Swinkels DW, Geurts-Moespot AJ, den Heijer M, Atsma F. Donation intensity and metabolic syndrome in active whole-blood donors. Vox Sang. 2015;109(1):25-34.
12. Salvin HE, Pasricha SR, Marks DC, Speedy J. Iron deficiency in blood donors: a national cross-sectional study. Transfusion. 2014;54(10): 2434-2444.
13. Milman N, Søndergaard M. Iron stores in male blood donors evaluated by serum ferritin. Transfusion. 1984;24(6):464-468.
14. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr. 2009;90(5):1280-1287.
15. Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood. 2014;124(4):479-482.
16. Mast AE, Kiss JE, Cable RG, Glynn SA, Brambilla D. Effects of storage iron on erythropoietin and hepcidin responses to acute hemorrhage [abstract]. Blood. 2014;124(21). Abstract 1351.
17. Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion. 2013;53(8):1637-1644.
18. Spencer BR, Kleinman S, Wright DJ, et al; REDS-II RISE Analysis Group. Restless legs syndrome, pica, and iron status in blood donors. Transfusion. 2013;53(8):1645-1652.
19. Waldvogel S, Pedrazzini B, Vaucher P et al. Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial. BMC Med. 2012;10:8.
20. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol. 2005;18(2):319-332.
21. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23(3):95-104.
22. Ferraro S, Mozzi R, Panteghini M. Revaluating serum ferritin as a marker of body iron stores in the traceability era. Clin Chem Lab Med. 2012;50(11): 1911-1916.
23. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7(2): 145-153.
24. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989.
25. Kiss JE, Brambilla D, Glynn SA, et al; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Oral iron supplementation after blood donation: a randomized clinical trial. JAMA. 2015;313(6):575-583.